# Roflumilast

NDC: 67877-730
Generic name: Roflumilast
Labeler / Manufacturer: Ascend Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20250314

FDA application: ANDA212490

## Active ingredients

- ROFLUMILAST: 250 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67877-730"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67877-730
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=93d72a99-64dc-4fde-a5b8-78331fa60787